Copyright Reports & Markets. All rights reserved.

Global Heparin Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Heparin Market Overview

      • 1.1 Product Overview and Scope of Heparin
      • 1.2 Heparin Segment by Type
        • 1.2.1 Global Heparin Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Heparin Sodium
        • 1.2.3 Heparin Calcium
        • 1.2.4 Other
      • 1.3 Heparin Segment by Application
        • 1.3.1 Heparin Consumption Comparison by Application (2014-2025)
        • 1.3.2 UFH
        • 1.3.3 LMWH
      • 1.3 Global Heparin Market by Region
        • 1.3.1 Global Heparin Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Heparin Market Size
        • 1.4.1 Global Heparin Revenue (2014-2025)
        • 1.4.2 Global Heparin Production (2014-2025)

      2 Global Heparin Market Competition by Manufacturers

      • 2.1 Global Heparin Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Heparin Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Heparin Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Heparin Production Sites, Area Served, Product Types
      • 2.5 Heparin Market Competitive Situation and Trends
        • 2.5.1 Heparin Market Concentration Rate
        • 2.5.2 Heparin Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Heparin Production Market Share by Regions

      • 3.1 Global Heparin Production Market Share by Regions
      • 3.2 Global Heparin Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Heparin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Heparin Production
        • 3.4.1 North America Heparin Production Growth Rate (2014-2019)
        • 3.4.2 North America Heparin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Heparin Production
        • 3.5.1 Europe Heparin Production Growth Rate (2014-2019)
        • 3.5.2 Europe Heparin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Heparin Production (2014-2019)
        • 3.6.1 China Heparin Production Growth Rate (2014-2019)
        • 3.6.2 China Heparin Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Heparin Production (2014-2019)
        • 3.7.1 Japan Heparin Production Growth Rate (2014-2019)
        • 3.7.2 Japan Heparin Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Heparin Consumption by Regions

      • 4.1 Global Heparin Consumption by Regions
      • 4.2 North America Heparin Consumption (2014-2019)
      • 4.3 Europe Heparin Consumption (2014-2019)
      • 4.4 China Heparin Consumption (2014-2019)
      • 4.5 Japan Heparin Consumption (2014-2019)

      5 Global Heparin Production, Revenue, Price Trend by Type

      • 5.1 Global Heparin Production Market Share by Type (2014-2019)
      • 5.2 Global Heparin Revenue Market Share by Type (2014-2019)
      • 5.3 Global Heparin Price by Type (2014-2019)
      • 5.4 Global Heparin Production Growth by Type (2014-2019)

      6 Global Heparin Market Analysis by Applications

      • 6.1 Global Heparin Consumption Market Share by Application (2014-2019)
      • 6.2 Global Heparin Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Heparin Business

      • 7.1 Hepalink
        • 7.1.1 Hepalink Heparin Production Sites and Area Served
        • 7.1.2 Heparin Product Introduction, Application and Specification
        • 7.1.3 Hepalink Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Changshan Pharm
        • 7.2.1 Changshan Pharm Heparin Production Sites and Area Served
        • 7.2.2 Heparin Product Introduction, Application and Specification
        • 7.2.3 Changshan Pharm Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Qianhong Bio-pharma
        • 7.3.1 Qianhong Bio-pharma Heparin Production Sites and Area Served
        • 7.3.2 Heparin Product Introduction, Application and Specification
        • 7.3.3 Qianhong Bio-pharma Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Opocrin
        • 7.4.1 Opocrin Heparin Production Sites and Area Served
        • 7.4.2 Heparin Product Introduction, Application and Specification
        • 7.4.3 Opocrin Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Pfizer
        • 7.5.1 Pfizer Heparin Production Sites and Area Served
        • 7.5.2 Heparin Product Introduction, Application and Specification
        • 7.5.3 Pfizer Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Aspen Oss
        • 7.6.1 Aspen Oss Heparin Production Sites and Area Served
        • 7.6.2 Heparin Product Introduction, Application and Specification
        • 7.6.3 Aspen Oss Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 King-friend Biochemical Pharmaceutical
        • 7.7.1 King-friend Biochemical Pharmaceutical Heparin Production Sites and Area Served
        • 7.7.2 Heparin Product Introduction, Application and Specification
        • 7.7.3 King-friend Biochemical Pharmaceutical Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Bioibérica
        • 7.8.1 Bioibérica Heparin Production Sites and Area Served
        • 7.8.2 Heparin Product Introduction, Application and Specification
        • 7.8.3 Bioibérica Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Dongcheng Biochemicals
        • 7.9.1 Dongcheng Biochemicals Heparin Production Sites and Area Served
        • 7.9.2 Heparin Product Introduction, Application and Specification
        • 7.9.3 Dongcheng Biochemicals Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Jiulong Biochemicals
        • 7.10.1 Jiulong Biochemicals Heparin Production Sites and Area Served
        • 7.10.2 Heparin Product Introduction, Application and Specification
        • 7.10.3 Jiulong Biochemicals Heparin Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Tiandong
      • 7.12 Xinbai
      • 7.13 Yino Pharma Limited
      • 7.14 Deebio

      8 Heparin Manufacturing Cost Analysis

      • 8.1 Heparin Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Heparin
      • 8.4 Heparin Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Heparin Distributors List
      • 9.3 Heparin Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Heparin Market Forecast

      • 11.1 Global Heparin Production, Revenue Forecast
        • 11.1.1 Global Heparin Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Heparin Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Heparin Price and Trend Forecast (2019-2025)
      • 11.2 Global Heparin Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Heparin Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Heparin Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Heparin Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Heparin Production, Revenue Forecast (2019-2025)
      • 11.3 Global Heparin Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Heparin Consumption Forecast (2019-2025)
        • 11.3.2 Europe Heparin Consumption Forecast (2019-2025)
        • 11.3.3 China Heparin Consumption Forecast (2019-2025)
        • 11.3.4 Japan Heparin Consumption Forecast (2019-2025)
      • 11.4 Global Heparin Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Heparin Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
        Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.

        Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.

        The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.

        Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%

        Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.

        Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.

        The global Heparin market is valued at 990 million US$ in 2018 is expected to reach 1290 million US$ by the end of 2025, growing at a CAGR of 3.4% during 2019-2025.
        This report focuses on Heparin volume and value at global level, regional level and company level. From a global perspective, this report represents overall Heparin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Hepalink
        Changshan Pharm
        Qianhong Bio-pharma
        Opocrin
        Pfizer
        Aspen Oss
        King-friend Biochemical Pharmaceutical
        Bioibérica
        Dongcheng Biochemicals
        Jiulong Biochemicals
        Tiandong
        Xinbai
        Yino Pharma Limited
        Deebio

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Heparin Sodium
        Heparin Calcium
        Other

        Segment by Application
        UFH
        LMWH

        Buy now